The Awards have become a mark of distinction in Asian private equity, and a showcase for first-class innovation, ingenuity and performance. They are also unique in the region in how they are distributed - relying primarily on nominations and votes cast by Asia's entire private equity and venture capital community, but with contributions from a select panel of industry judges as well as the AVCJ Editorial Board. To be selected as a winner is to be truly acknowledged as preeminent.
Fundraising of the Year – Venture Capital: A91 Partners Fund I (A91 Partners)
Fundraising of the Year – Mid Cap: ChrysCapital VIII (ChrysCapital Partners)
Fundraising of the Year – Large Cap: PAG Asia III (PAG Asia Capital)
Deal of the Year – Small Cap: AffaMed Therapeutics (CBC Group)
Deal of the Year – Mid Cap: Hangzhou UCO Cosmetics (CITIC Capital)
Deal of the Year – Large Cap: Baosteel Gases (PAG Asia Capital)
Exit of the Year – IPO: Innovent Biologics (6 Dimensions Capital/Ally Bridge Group/Capital Group Private Markets/Cormorant Asset Management/Cowin Capital/Eight Roads Ventures/F-Prime Capital/Hillhouse Capital/Legend Capital/Lilly Asia Ventures/Rock Springs Capital/Temasek Holdings)
Exit of the Year – Small Cap: Gong Cha Kore (Unison Capital)
Exit of the Year – Mid Cap: Manuka Health (Pacific Equity Partners)
Exit of the Year – Large Cap: KCF Technologies (KKR))
Responsible Investment Award: Organica (SEAF)
Operational Value Add Award: EuroKids International (Gaja Capital)
Firm of the Year – Mid Cap: Centurium Capital
Firm of the Year – Large Cap: PAG Asia Capital
AVCJ Special Achievement Award: Renuka Ramnath